fingolimod hydrochloride has been researched along with Encephalitis, Herpes Zoster in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hentati, A; Issa, NP | 1 |
Bourdette, D; Gilden, D | 1 |
Calabresi, PA; Costello, K; Ratchford, JN; Reich, DS | 1 |
3 other study(ies) available for fingolimod hydrochloride and Encephalitis, Herpes Zoster
Article | Year |
---|---|
VZV encephalitis that developed in an immunized patient during fingolimod therapy.
Topics: Encephalitis, Varicella Zoster; Female; Fingolimod Hydrochloride; Herpes Zoster Vaccine; Humans; Immunocompromised Host; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis, Chronic Progressive; Propylene Glycols; Sphingosine | 2015 |
Fingolimod and multiple sclerosis: four cautionary tales.
Topics: Antibodies, Monoclonal, Humanized; Brain; Cerebrovascular Disorders; Encephalitis, Varicella Zoster; Female; Fingolimod Hydrochloride; Herpes Zoster; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Male; Multiple Sclerosis; Natalizumab; Nerve Fibers, Myelinated; Propylene Glycols; Sphingosine | 2012 |
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Topics: Brain; Cerebrovascular Disorders; Encephalitis, Varicella Zoster; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Propylene Glycols; Sphingosine | 2012 |